| Date | Title | Description |
| 29.02.2024 | 6 challenges in rare disease research and how we can overcom... | Rare conditions, individually, have low patient numbers. However, with more than 7,000 rare diseases... |
| 10.11.2023 | LifeArc-funded documentary highlights pioneering scientific ... | A new documentary has been released which follows a key discovery made by researchers at University ... |
| 03.11.2023 | LifeArc helps fund new research institute to accelerate the ... | A new research institute to accelerate the search for a cure for motor neuron disease (MND, also kno... |
| 20.10.2023 | 3 LifeArc Ventures’ portfolio companies celebrated in new re... | With the UK setting its sights on becoming a global life sciences superpower, it has created an envi... |
| 19.10.2023 | New £30m initiative to address global threat by accelerating... |
As part of LifeArc’s global health strategy, we’re committed to reducing the number of lives lost ... |
| 02.10.2023 | LifeArc welcomes Stéphane Maikovsky as Interim CEO | LifeArc, the self-funded, not-for-profit medical research organisation today announced the appointme... |
| 26.09.2023 | LifeArc welcomes new lead and chair to head its Childhood Ca... | LifeArc welcomes the arrival of a new Translational Challenge Lead, Dr David Jenkinson, and Chair, P... |
| 14.09.2023 | Unveiling the future of cell and gene therapies in the UK | In recent years, cell and gene therapies have been advancing at lightning speed, offering new hope t... |
| 12.09.2023 | Dr Melanie Lee CBE steps down as CEO of LifeArc | Dr. Melanie Lee has notified the Board of her decision to step down as Chief Executive Officer, effe... |
| 07.09.2023 | LifeArc welcomes news of the UK rejoining Horizon Europe, th... | Today the UK and EU agreed a deal for the UK to associate the world’s largest collaborative research... |
| 14.08.2023 | LifeArc and the Francis Crick Institute partner with five Af... | The Crick Africa Network (CAN) is set to extend for a further five years, supporting more young Afri... |
| 10.08.2023 | LifeArc joins Infection Innovation Consortium to help tackle... | LifeArc has entered into a partnership with the Liverpool School of Tropical Medicine (LSTM) and wil... |
| 11.07.2023 | New Alzheimer’s treatment ‘lecanemab’ approved for use in th... | The therapeutic antibody lecanemab (LeqembiTM) has received full market approval by the US Food and ... |
| 10.07.2023 | LifeArc and DEBRA Austria launch £2.5m funding call for repu... | LifeArc, the self-funded, non-profit, medical research organisation and charity, and DEBRA Austria, ... |
| 06.07.2023 | Groundbreaking new £100m LifeArc programme aims to improve t... |
LifeArc, the self-funded, non-profit medical research organisation and charity, is launching a... |
| 06.07.2023 | Catriona Crombie talks to Rare Revolution about LifeArc’s in... | This article was originally published in Rare Revolution Magazine
LifeArc, a self-financing medical... |
| 29.06.2023 | New UK-based research project brings together world-leading ... | 29 June, 2023 – Eisai, Gates Ventures, Health Data Research UK (HDR UK), LifeArc and The University ... |
| 27.06.2023 | LifeArc strengthens Board of Trustees with new appointments | LifeArc, the self-funded medical research organisation, announces today that Dr Terri Cooper, Dr Sam... |
| 21.06.2023 | New programme to move potential MND drugs into clinical tria... | A ground-breaking experimental medicine programme that will enable researchers to more rapidly scree... |
| 21.06.2023 | How LifeArc’s Neurodegeneration Translational Challenge is l... | June 21st is Global MND Awareness Day, a day to raise worldwide awareness of MND (Motor Neurone Dise... |
| 30.05.2023 | LifeArc and Sarcoma UK fund research to guide treatment deci... | A £150,000 grant from LifeArc and the charity Sarcoma UK will fund a study of a new biomarker test t... |
| 15.05.2023 | LifeArc announces strategic partnership with PrecisionLife a... | London and Oxford, UK, 15 May 2023 – Self funded, not-for-profit medical research organisation LifeA... |
| 11.05.2023 | Meet our industrial placement students – class of 2023 | Every year LifeArc runs a salaried industrial placement scheme for up to 12 students. They develop v... |
| 11.05.2023 | LifeArc & Cystic Fibrosis Trust announce new £15m resear... | A new exciting and innovative £15m research programme has been announced to help improve the lives o... |
| 09.05.2023 | Translational research into children’s rare diseases enters ... | LifeArc is proud to be renewing our joint funding collaboration with Action Medical Research, a lead... |
| 02.05.2023 | Dr Jason Slingsby joins LifeArc as Chief Business Officer | LifeArc, the self-funded medical research charity, announces today that Dr Jason Slingsby has joined... |
| 24.04.2023 | LifeArc launches £40m funding call to create Translational R... | 24 April 2023: LifeArc is inviting applications from academic institutions for its latest £40m initi... |
| 20.04.2023 | LifeArc plans two major funding calls to boost translational... | LifeArc is set to announce two major funding calls in the following weeks which will support the acc... |
| 13.04.2023 | Talking to FLIER future leaders about learning from COVID-19... | By Dr Melanie Lee CBE, CEO
Scientists have always understood the value of collaborative working. Bu... |
| 12.04.2023 | LifeArc joins the Campaign for Science and Engineering | Today LifeArc became the newest member of the Campaign for Science and Engineering (CaSE).
This net... |
| 11.04.2023 | Highlights from Illumina for Startups Summit 2023 | By Dr Melanie Lee CBE, CEO
Last month I was pleased to take part online in a fireside chat at the I... |
| 23.03.2023 | LifeArc Ventures launches new brand with dedicated website, ... | LifeArc Ventures, which provides ventures investment for early-stage science-led companies, is growi... |
| 21.03.2023 | From donkeys to diversity – Anji Miller reports from AUTM 20... | I attended this year’s AUTM annual meeting last month with Madhu Madhusudhan, Chris Baker, Laura Ste... |
| 16.03.2023 | £3m fund to accelerate development of new CF therapies | LifeArc, as part of the CF AMR Syndicate, is providing £3m in collaborative funding to drug discover... |
| 15.03.2023 | LifeArc responds to the Government’s Spring Budget | LifeArc CEO Dr Melanie Lee responds to today’s Spring Budget:
“With the right Government support, w... |
| 08.03.2023 | International Women’s Day 2023 | This International Woman’s Day, we hear from some of LifeArc’s incredible women who are paving the w... |
| 01.03.2023 | The Aisling Burnand Daphne Jackson Research Fellowship, spon... | The Board at LifeArc announces today it is sponsoring five Daphne Jackson Fellowships, in honour of ... |
| 28.02.2023 | LifeArc awards £3 million to advance promising early rare di... | LifeArc has awarded £3 million to de-risk and accelerate around 30 innovative early research project... |
| 28.02.2023 | Rare Disease Day 2023 – Robbie’s story | For Rare Disease Day 2023, we shine a light on a partnership that aims to accelerate the search for ... |
| 28.02.2023 | Four ways we support rare disease research | Medicine research and development is challenging and takes a long time. With licensed medicines only... |
| 28.02.2023 | Honouring the contribution of a remarkable trustee – Aisling... | By Dr Melanie Lee CBE, CEO
It is hard to find the right words to pay tribute to Aisling Burnand, he... |
| 15.02.2023 | LifeArc Ventures invests in Maxion Therapeutics | LONDON, UK, 15 February 2023 – LifeArc Ventures, the investment arm of LifeArc, today announced its ... |
| 10.02.2023 | Celebrating the International Day of Women and Girls in Scie... | “Science wins when it gets the brightest minds and talents, and that means everyone must have an equ... |
| 01.02.2023 | LifeArc Ventures – strong performance in 2022 & sustaine... | Highlights
LONDON, UK, 1 February 2023 — LifeArc Ventures, which is committed to investing in innov... |
| 24.01.2023 | £1 million awarded to develop cutting-edge therapies for mot... |
London, 24 January 2023: Medical research charity LifeArc, the Motor Neurone Disease Association (... |
| 10.01.2023 | LifeArc portfolio company RQ Bio’s antibody enters clinical ... | LifeArc Ventures’ portfolio company RQ Biotechnology has announced that the first of its discovered ... |
| 06.01.2023 | Alzheimer’s drug lecanemab approved by US regulator | On the news that lecanemab – a promising new therapeutic antibody that we played a small but importa... |
| 21.12.2022 | Evolving our science to solve complex healthcare challenges | Dr Dave Powell joined LifeArc as our first Chief Scientific Officer earlier this year. He brings mor... |
| 20.12.2022 | 2022 wrapped – our highlights from a pivotal year | As another turbulent year draws to a close, we’ve been looking back at a significant year for LifeAr... |
| 15.12.2022 | LifeArc partners with EMBARC to improve healthcare for peopl... | LifeArc is partnering with the European Multicentre Bronchiectasis Audit and Research Collaboration ... |
| 12.12.2022 | MND Collaborative Partnership cautiously welcomes new Govern... | We cautiously welcome the announcement from the Government outlining how the £50 million investment ... |
| 08.12.2022 | Repurposed flu medicine could help under 60s recover faster ... | A flu medicine called favipiravir could help people under 60 recover more quickly from COVID-19, acc... |
| 01.12.2022 | LifeArc bolsters executive team with communications expertis... | Welcome to Anna Tomlinson, who joins LifeArc as our first Chief Communications Officer. Anna will jo... |
| 23.11.2022 | LifeArc announces £10m funding call for new chronic respirat... | LifeArc is committing £10m to fund up to five collaborative projects that seek to repurpose existing... |
| 22.11.2022 | £100m programme to transform care for people living with chr... | LifeArc is launching a landmark £100m programme to urgently develop new healthcare solutions for the... |
| 17.11.2022 | LifeArc responds to the Government’s renewed pledge to incre... | LifeArc CEO Dr Melanie Lee welcomes the Government’s restatement of its commitment to increase R&... |
| 16.11.2022 | LifeArc plays key role in discovery of new Alzheimer’s treat... | Our antibody humanisation work played an important part in the discovery of lecanemab, an experiment... |
| 16.11.2022 | LifeArc funds home monitoring trials for people with chronic... | LifeArc is partnering with researchers at Royal Papworth Hospital NHS Foundation Trust to fund new U... |
| 15.11.2022 | LifeArc Ventures invests in Surgery Hero, world’s first digi... | LONDON, UK – LifeArc Ventures, the investment arm of LifeArc, today announced its participation in a... |
| 11.11.2022 | Call for Government to place medical research at the heart o... | Ahead of the Autumn Statement, LifeArc and other leading life science organisations have written to ... |
| 21.10.2022 | LifeArc contributes to organic chemistry breakthrough | LifeArc scientists, working with researchers in Manchester, have contributed to a fundamental breakt... |
| 20.10.2022 | AbbVie acquires LifeArc portfolio company DJS Antibodies | AbbVie (NYSE: ABBV) has acquired LifeArc’s portfolio company DJS Antibodies Limited (“DJS”), a priva... |
| 13.10.2022 | LifeArc’s new fund to advance gene-based medicines for genet... | Researchers can now apply to LifeArc’s new £5 million Gene Therapy Innovation Fund to progress their... |
| 10.10.2022 | New toolkit launched to help repurposed medicines reach pati... | Charities, researchers and others hoping to repurpose existing medicines for treating other diseases... |
| 07.10.2022 | LifeArc scientist awarded prestigious industrial fellowship | LifeArc scientist Finbar Gaffey has been selected as one of 10 young innovators to receive a coveted... |
| 28.09.2022 | LifeArc joins forces with Cystic Fibrosis Trust and Medicine... | Pivotal partnership seeks to transform cystic fibrosis research
LifeArc, a national medical researc... |
| 22.09.2022 | Aisling Burnand CBE, 1964-2022 | It is with deep sadness that we share the news that our trustee, colleague and friend, Aisling Burna... |
| 21.09.2022 | Separate science from politics: save the UK’s science sector... | The current direction of the Horizon Europe situation is a cause of concern. Exclusion of the United... |
| 16.09.2022 | Promising new antibody treatment for osteoporosis and multip... | LifeArc scientists, in collaboration with Prof. Thomas Worzfeld and Prof. Stefan Offermanns from Mar... |
| 09.09.2022 | Her Majesty Queen Elizabeth II | We at LifeArc are deeply saddened by the passing of our monarch, Her Majesty Queen Elizabeth II.
We... |
| 08.09.2022 | LifeArc portfolio company Ducentis BioTherapeutics acquired ... | LONDON, UK, 08 September 2022 — LifeArc today announced that its portfolio company Ducentis BioThera... |
| 06.09.2022 | Seven questions about LifeArc’s 2030 ambitions |
At LifeArc, we have an ambitious goal – to spend £1.3 billion by 2030, translating science into me... |
| 01.09.2022 | LifeArc helps create new MRC spin-out company | Our technology transfer team played a crucial role in the formation of Constructive Bio, a new Medic... |
| 17.08.2022 | Driving translational research into childhood rare diseases | LifeArc and Great Ormond Street Hospital Children’s charity (GOSH) have jointly awarded more than £1... |
| 27.07.2022 | Advancing novel gene therapies into the clinic | One year on, we report on the progress made to date to establish a national network of Innovation Hu... |
| 26.07.2022 | Study reveals potential new way to treat colorectal cancer | Scientists have discovered an IL-17B receptor (also known as IL-25 receptor) antibody could be used ... |
| 21.07.2022 | Startup wins first Advise & Connect Innovation Award | During the pandemic, we launched the Advise & Connect service as part of our wider effort as an ... |
| 27.06.2022 | Milner Therapeutics Institute and LifeArc extend strategic p... | Our collaboration with the Milner Therapeutics Institute has been expanded into a five year strategi... |
| 21.06.2022 | New £4.25 million grant kick starts UK-wide collaborative re... | A group of charities and government research organisations has awarded £4.25 million to MND experts ... |
| 16.06.2022 | New £30 million translational partnership will accelerate de... | LifeArc and the UK Dementia Research Institute (UK DRI) have today launched a new partnership to acc... |
| 15.06.2022 | Promising new asthma medicine ready to enter early clinical ... | LifeArc scientists were instrumental to the development of the world’s first monoclonal antibody tar... |
| 18.05.2022 | Pandemic Science Hub to develop better drugs to fight lung d... | A new multi-million pound research programme at the University of Edinburgh will develop treatments ... |
| 17.05.2022 | LifeArc co-founded company RQ Bio signs licensing agreement ... | LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it c... |
| 17.05.2022 | Action Medical Research and LifeArc announce another round o... | Children’s charity Action Medical Research and independent medical research charity LifeArc are plea... |
| 13.05.2022 | Accelerating progress against dementia | – by Dr Melanie Lee, CEO
It is a shocking fact that, according to the Dementia Statistics Hub, one ... |
| 05.05.2022 | Learning from translational research success stories during ... | by Dr Melanie Lee, CEO
I recently chaired a panel at a Royal Society event that took us behind the ... |
| 27.04.2022 | Hackathon brings scientists together to tackle brain health | Together with the patient charity Motor Neurone Disease (MND) Association, LifeArc co-sponsored an M... |
| 24.03.2022 | LifeArc and Scottish Government work together to drive Scott... | LifeArc and the Chief Scientist Office (CSO) for the Scottish Government have today jointly awarded ... |
| 18.03.2022 | Covid-19 hub shortlisted for Scottish award | CRUSH, a Covid-19 hub enabling the delivery of translational science in the virology field and co-fu... |
| 07.03.2022 | Study reveals gene faults underpinning severe Covid-19 | The world’s largest study of the genetics of severe Covid-19, that we have helped to fund, reveals f... |
| 28.02.2022 | Living with a rare but incurable liver disease | A young actor battled a rare liver disease through college and drama school before getting fit enoug... |
| 28.02.2022 | Can an innovative gene therapy help people with Hunter syndr... | Hunter syndrome, also called mucopolysaccharidosis type II, is a rare genetic disease that almost al... |
| 28.02.2022 | LifeArc – advancing innovation in rare disease | There are more than 7,000 rare diseases. A rare disease is defined as one that affects less than 1 i... |
| 28.02.2022 | Living with genetic sight loss – a family story | Late-onset retinal degeneration (L-ORD) is a rare inherited eye disease that leads to blindness in o... |
| 16.02.2022 | LifeArc elects new Board Chair to drive charity’s ambitious ... | Dr Ian Gilham has been appointed as our new Chair of Trustees and will succeed Dr John Stageman CBE ... |
| 15.02.2022 | New study explores unique approach to treat a rare liver dis... | A UK research study looking into a new approach to treat primary sclerosing cholangitis (PSC) – a ra... |
| 11.02.2022 | Celebrating our inspirational women scientists | Today is the UN’s International Day of Women and Girls in Science and we are delighted to have so ma... |
| 01.02.2022 | LifeArc bolsters scientific leadership by appointing new Chi... | Welcome to Dr Dave Powell, who has joined LifeArc as our first Chief Scientific Officer (CSO). Dave ... |
| 22.12.2021 | Reflecting on 2021 – a year of progress | As we bid farewell to another challenging year, we reflect on everything that has happened during 20... |
| 08.12.2021 | LifeArc appoints first Chief Operating Officer | Richard Godfrey has joined LifeArc as its first Chief Operating Officer (COO). The new role will str... |
